GOOD NEWS 24

Only good news.

Optimistic news only — science, medicine, climate progress, society, animals and hopeful things that make the day feel lighter.

✨ All 330 🔬 Science 70 🌿 Nature 31 🤝 Society 33 💡 Technology 11 🩺 Medicine 70 🐾 Animals 58 🌍 World 7 🌱 Climate change 37 📚 Education 2 🏆 Sports 2 ⭐ Heroes 4

TOP STORIES

Medicine stories

Surprise me ☀️

MORE GOOD NEWS

70 matching stories

Clear filters
Doctors Applied Stem Cells to Babies' Spines Before Birth. The Results Are Extraordinary.
Medicine

Doctors Applied Stem Cells to Babies' Spines Before Birth. The Results Are Extraordinary.

A world-first trial at UC Davis Health has shown that applying placenta-derived stem cells to a fetus's spine during in-utero surgery for spina b…

Chile Has Become the First Country in the Americas to Officially Eliminate Leprosy
Medicine

Chile Has Become the First Country in the Americas to Officially Eliminate Leprosy

The World Health Organization has officially verified Chile as having eliminated leprosy — making it the first country in the Americas, and only …

Scientists Grew Fully Functional Hair Follicles in a Lab for the First Time — and They Naturally Cycle Through Growth
Medicine

Scientists Grew Fully Functional Hair Follicles in a Lab for the First Time — and They Naturally Cycle Through Growth

US and Japanese researchers have cracked a longstanding puzzle in biotech: growing hair follicles in the lab that actually work. By identifying a…

Stopping Ozempic Doesn't Mean the Weight Comes Back — A Major Study Just Proved It
Medicine

Stopping Ozempic Doesn't Mean the Weight Comes Back — A Major Study Just Proved It

A new Cleveland Clinic study of nearly 8,000 real-world patients found that 45% of people who stopped taking GLP-1 drugs like Ozempic either main…

Scientists Engineered a Bacteria to Sneak Into Tumours and Make Cancer Drugs From the Inside
Medicine

Scientists Engineered a Bacteria to Sneak Into Tumours and Make Cancer Drugs From the Inside

Researchers have reprogrammed the probiotic bacterium E. coli Nissle 1917 to infiltrate solid tumours in mice and produce the FDA-approved antica…

Psilocybin Just Passed Its Second Phase 3 Trial for Treatment-Resistant Depression — FDA Filing Planned for Late 2026
Medicine

Psilocybin Just Passed Its Second Phase 3 Trial for Treatment-Resistant Depression — FDA Filing Planned for Late 2026

Compass Pathways' COMP360 synthetic psilocybin has now passed two pivotal Phase 3 trials for treatment-resistant depression, meeting primary endp…

Tiny Magnetic Microrobots Can Now Navigate to Tumours, Track Themselves in Real Time, and Destroy Cancer Cells With Heat — All in One Device
Medicine

Tiny Magnetic Microrobots Can Now Navigate to Tumours, Track Themselves in Real Time, and Destroy Cancer Cells With Heat — All in One Device

Michigan State University, Henry Ford Health, and Arizona State University have developed TriMag — microrobots smaller than a human hair that com…

A Single Injection of Engineered Brain Cells Cleared Half of Alzheimer's Plaques in Mice — Published in Science
Medicine

A Single Injection of Engineered Brain Cells Cleared Half of Alzheimer's Plaques in Mice — Published in Science

Washington University scientists engineered astrocytes — the brain's most abundant support cells — with the same CAR 'homing device' used in canc…

The FDA Just Approved the First Immunotherapy Combination for Newly Diagnosed Advanced Hodgkin Lymphoma
Medicine

The FDA Just Approved the First Immunotherapy Combination for Newly Diagnosed Advanced Hodgkin Lymphoma

The FDA has approved nivolumab (Opdivo) in combination with standard chemotherapy as a frontline treatment for Stage III and IV classical Hodgkin…

A Gene Therapy for a Rare Immune Disease That Kills Children Has Achieved 100% Survival — and the FDA Is About to Decide
Medicine

A Gene Therapy for a Rare Immune Disease That Kills Children Has Achieved 100% Survival — and the FDA Is About to Decide

Rocket Pharmaceuticals' gene therapy Kresladi is awaiting FDA approval by March 28, 2026, for a rare immune disorder called LAD-1 that is near-un…

UK Cancer Deaths Have Fallen to Their Lowest Level on Record — Down 29% Since 1989
Medicine

UK Cancer Deaths Have Fallen to Their Lowest Level on Record — Down 29% Since 1989

New statistics from Cancer Research UK show that cancer death rates have fallen nearly 29% since their 1989 peak — from 355 deaths per 100,000 to…

Scientists Are Testing a Vaccine Built From Folded DNA — and It May Outperform mRNA
Medicine

Scientists Are Testing a Vaccine Built From Folded DNA — and It May Outperform mRNA

A new vaccine platform called DoriVac uses 'DNA origami' — precisely folded DNA nanostructures — to present antigens to the immune system in a mo…

A Single mRNA Injection Can Heal a Damaged Heart After a Heart Attack — Even If Given Days Later
Medicine

A Single mRNA Injection Can Heal a Damaged Heart After a Heart Attack — Even If Given Days Later

Researchers at Temple University have developed an mRNA-based therapy that, in a single injection, activates cardiac regeneration in mice after a…

Breakthrough Ovarian-Cancer Therapy Achieves 95% Remission Rate
Medicine

Breakthrough Ovarian-Cancer Therapy Achieves 95% Remission Rate

A new 'genetic blueprint' therapy from Melbourne's Peter MacCallum Cancer Centre has achieved a 95% long-term remission rate in treated patients.

World Health Day 2026 Launches Global ‘Stand With Science’ Campaign
Medicine

World Health Day 2026 Launches Global ‘Stand With Science’ Campaign

WHO has launched a year-long World Health Day 2026 campaign focused on science-led health progress and international collaboration.

WHO Clears the First-Ever Malaria Treatment Made Specifically for Newborns and Tiny Infants
Medicine

WHO Clears the First-Ever Malaria Treatment Made Specifically for Newborns and Tiny Infants

In a major breakthrough announced on April 24, 2026, WHO prequalified the first malaria treatment designed specifically for newborns and young in…

FEEL BETTER DAILY

One good thing in your inbox.

Short, kind, useful and hopeful. No doom-scrolling required.